Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
Missed the 15th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
An analysis of journal article abstracts provides further insight into the role of reporting guidelines and medical writers in the transparent reporting of clinical trial data.